Calithera Biosciences, Inc. (NASDAQ:CALA), announced that clinical data from its lead product candidate CB-839, a first-in-class glutaminase inhibitor ...
News
- Trending Tickers: Calithera Biosciences, Inc. (NASDAQ:CALA), Ultratech, Inc. (NASDAQ:UTEK ...
- Royalty from Belgium visit the Alamo City
There, the delegates learned how San Antonio is a city with a vibrant biomedical and healthcare sector, and how Belgium can benefit from a ...
- Calithera Biosciences Reports CB-839 Phase I Triple Negative Breast Cancer Combination Data at ...
Calithera Biosciences (Nasdaq:CALA), a clinical stage biotechnology ... 2016 San Antonio Breast Cancer Symposium, December 6-10, 2016 in San ...
- City Welcomes Princess Astrid of Belgium to San Antonio
... before leading the princess into the building for a focus session on San Antonio's cybersecurity, advanced research, and biomedical and health care ...
- Royalty from Belgium visit the Alamo City
SAN ANTONIO - On Tuesday, royalty enjoyed the River Walk as the ... the delegates learned how San Antonio is a city with a vibrant biomedical and ...